Literature DB >> 9223586

[125I]IPH, an epibatidine analog, binds with high affinity to neuronal nicotinic cholinergic receptors.

M I Dávila-García1, J L Musachio, D C Perry, Y Xiao, A Horti, E D London, R F Dannals, K J Kellar.   

Abstract

An analog of epibatidine (EB) was synthesized with an iodine atom in the 2 position of the pyridyl ring. This analog, (+/-)-exo-2-(2-iodo-5-pyridyl)-7-azabicyclo[2.2.1]heptane (IPH), as well as its two stereoisomers, displayed high affinity for neuronal nicotinic receptors; therefore, radioiodinated IPH, [125I]IPH, was synthesized with specific radioactivities consistently > 1000 Ci/mmol, and its properties as a radioligand for neuronal nicotinic receptors were evaluated. The characteristics of [125I]IPH binding in tissue homogenates appeared to be virtually identical to those reported for [3H]epibatidine binding; but the high specific radioactivity of [125I]IPH greatly facilitated measurements of nicotinic receptors in tissues with relatively low receptor densities and/or where tissues are in limited supply. Autoradiography with [125I]IPH provided clear localization of nicotinic receptors in brain and adrenal gland after film exposure times of < or = 2 days. We conclude that [125I]IPH will be a very useful radioligand for the study of neuronal nicotinic receptors in brain and in peripheral ganglia.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9223586

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  18 in total

1.  Effects of chronic nicotine on heteromeric neuronal nicotinic receptors in rat primary cultured neurons.

Authors:  Ermelinda Lomazzo; Gregory P Hussmann; Barry B Wolfe; Robert P Yasuda; David C Perry; Kenneth J Kellar
Journal:  J Neurochem       Date:  2011-09-01       Impact factor: 5.372

2.  An autoradiographic survey of mouse brain nicotinic acetylcholine receptors defined by null mutants.

Authors:  Christopher G Baddick; Michael J Marks
Journal:  Biochem Pharmacol       Date:  2011-05-10       Impact factor: 5.858

3.  Vulnerability of 125I-alpha-conotoxin MII binding sites to nigrostriatal damage in monkey.

Authors:  M Quik; Y Polonskaya; J M Kulak; J M McIntosh
Journal:  J Neurosci       Date:  2001-08-01       Impact factor: 6.167

4.  Antagonism of nicotinic receptors of rat chromaffin cells by N,N, N-trimethyl-1-(4-trans-stilbenoxy)-2-propylammonium iodide: a patch clamp and ligand binding study.

Authors:  S Di Angelantonio; A Nistri; M Moretti; F Clementi; C Gotti
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

Review 5.  Functional brain imaging of tobacco use and dependence.

Authors:  Arthur L Brody
Journal:  J Psychiatr Res       Date:  2005-06-24       Impact factor: 4.791

6.  [¹²⁵I]AT-1012, a new high affinity radioligand for the α3β4 nicotinic acetylcholine receptors.

Authors:  Jinhua Wu; David C Perry; James E Bupp; Faming Jiang; Willma E Polgar; Lawrence Toll; Nurulain T Zaveri
Journal:  Neuropharmacology       Date:  2013-10-03       Impact factor: 5.250

Review 7.  Nicotinic agonists, antagonists, and modulators from natural sources.

Authors:  John W Daly
Journal:  Cell Mol Neurobiol       Date:  2005-06       Impact factor: 5.046

Review 8.  In vivo brain imaging of human exposure to nicotine and tobacco.

Authors:  Anil Sharma; Arthur L Brody
Journal:  Handb Exp Pharmacol       Date:  2009

9.  Palmitoylation of nicotinic acetylcholine receptors.

Authors:  J K Alexander; A P Govind; R C Drisdel; M P Blanton; Y Vallejo; T T Lam; W N Green
Journal:  J Mol Neurosci       Date:  2009-08-20       Impact factor: 3.444

10.  John Daly's compound, epibatidine, facilitates identification of nicotinic receptor subtypes.

Authors:  Michael J Marks; Duncan S Laverty; Paul Whiteaker; Outi Salminen; Sharon R Grady; J Michael McIntosh; Allan C Collins
Journal:  J Mol Neurosci       Date:  2009-08-12       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.